Delivery Order 36C24821D0025-36C24821N0338
Award Date 2/1/21
Potential Completion Date 1/31/22
Potential Value $94K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Port Chester, NY 10573, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Cytopath Biopsy Lab Inc., doing business as Cblpath, has been awarded a $12,000 firm fixed price delivery order contract for cytopathology and ThyroSeq testing services. The contract is associated with the Department of Veterans Affairs Veterans Health Administration's Veterans Integrated Service Network 4 and has a period of performance through May 31, 2023. Under this contract, Cblpath will provide cytopathology laboratory testing and molecular diagnostic testing for thyroid cancer to...
- Cytopath Biopsy Lab Inc., doing business as Cblpath, has been awarded a $120,000 firm fixed price delivery order for Thyrosequence Testing Services from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. The delivery order was issued on February 13, 2024 with a completion date of February 12, 2025. It is being performed in New York, NY under an existing Indefinite Delivery/Indefinite Quantity contract vehicle between Cblpath and VISN 2 for...
- The Department of Veterans Affairs Veterans Health Administration has awarded a $8,000.00 firm fixed price purchase order to Cytopath Biopsy Lab Inc., doing business as Cblpath, for thyroid molecular testing services. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with experience delivering ThyroSeq genetic testing to support cancer screening and diagnosis programs for the VA and Department of Defense. This contract is not set aside and is...
- Cytopath Biopsy Lab Inc., operating as Cblpath, has been awarded a $84,000 firm fixed-price Blanket Purchase Agreement (BPA) call for ThyroSeq genomic classifier tests by Veterans Integrated Service Network 6, a regional component of the Department of Veterans Affairs. The award, effective October 1, 2024 with an ultimate completion date of September 30, 2025, represents a task order under the broader BPA vehicle established between Cblpath and VISN 6. The contract utilizes no set-aside...
- This $64,400.00 firm fixed price delivery order was awarded to Cytopath Biopsy Lab Inc. (doing business as Cblpath) by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2. The order is for cytopathology and ThyroSequence genetic testing services to support the VA's cancer screening and diagnosis programs. Cblpath is a specialized anatomic pathology and molecular diagnostics laboratory that has previously provided ThyroSequence testing to the VA and Department of Defense...
- Cytopath Biopsy Lab Inc., doing business as Cblpath, has been awarded a firm fixed price contract valued at seventy-two thousand dollars by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19. The contract calls for Cblpath to provide molecular thyroid mutation reference testing services in support of the agency's research programs for one year under a Blanket Purchase Agreement call order. Place of performance will be in Port Chester, New...
- Cytopath Biopsy Lab Inc., doing business as Cblpath, was awarded a $287,225 firm fixed price blanket purchase agreement call contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1. The contract is for thyroid sequencing testing services to support VHA's healthcare programs. Cblpath will provide sequencing and analysis of thyroid samples to the VA medical center in Port Chester, New York. No set-aside designation was used for this...
- This contract award to Cytopath Biopsy Lab Inc., doing business as Cblpath, is for the provision of ThyroSeq Genomic Classifier Tests. The $70,000.00 firm fixed price contract was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA) on October 1, 2024, with a period of performance through September 30, 2025. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, with extensive experience...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Cytopath Biopsy Lab Inc., doing business as Cblpath, for $22,000.00 to provide ThyroSeQ testing services. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, primarily focused on cancer screening and diagnosis. This award is associated with Cblpath's existing Indefinite Delivery/Indefinite Quantity (IDIQ) and Blanket Purchase Agreement...
- This federal contract award to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath, is for $64,400.00 to provide CYTOPATHOLOGY & THYROSEQUENCE TESTING SERVICES. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 30, 2026. The funding agency is the Veterans Integrated Service Network 2, a civilian agency under the U.S. Department of Veterans Affairs. The contract does not have a set-aside designation. Cblpath is a for-profit...